Technical Analysis for NTRA - Natera, Inc.

Grade Last Price % Change Price Change
grade B 52.87 -4.17% -2.30
NTRA closed down 4.17 percent on Friday, August 7, 2020, on 75 percent of normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Up
Historical NTRA trend table...

Date Alert Name Type % Chg
Slingshot Bullish Bullish Swing Setup 0.00%
Calm After Storm Range Contraction 0.00%
Stochastic Reached Overbought Strength 0.00%
Upper Bollinger Band Walk Strength 0.00%
Overbought Stochastic Strength 0.00%
Upper Bollinger Band Touch Strength 0.00%
New 52 Week Closing High Bullish -4.17%
Expansion Breakout Bullish Swing Setup -4.17%
Pocket Pivot Bullish Swing Setup -4.17%
Doji - Bearish? Reversal -4.17%

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Natera, Inc., a genetic testing company, develops and commercializes non-invasive methods for analyzing deoxyribonucleic acid (DNA) in the United States and Europe. The company primarily offers Panorama, a non-invasive prenatal test for fetal chromosomal abnormalities; Horizon test; and pre-implantation genetic screening and pre-implantation genetic diagnosis tests under the Spectrum brand to analyze chromosomal anomalies or inherited genetic conditions during an in vitro fertilization. It also provides products of conception testing under the Anora brand to analyze fetal chromosomes to understand the cause of miscarriage; non-invasive paternity testing products to determine paternity by analyzing the fragments of fetal DNA in a pregnant mother's blood and a blood sample from the alleged father; and high throughput carrier screening to determine the risk of passing severe genetic diseases on to offspring. Natera sells its tests directly and partner with other clinical laboratories to distribute its tests. The company was formerly known as Gene Security Network, Inc. and changed its name to Natera, Inc. in 2012. Natera, Inc. was founded in 2003 and is headquartered in San Carlos, California.
Medicine Clinical Medicine Medical Tests Medical Genetics Applied Genetics DNA Genetic Testing DNA Paternity Testing In Vitro Fertilization Severe Genetic Diseases

Is NTRA a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 56.51
52 Week Low 16.87
Average Volume 735,189
200-Day Moving Average 38.47
50-Day Moving Average 46.59
20-Day Moving Average 48.79
10-Day Moving Average 49.43
Average True Range 2.47
ADX 18.26
+DI 33.44
-DI 12.12
Chandelier Exit (Long, 3 ATRs ) 49.09
Chandelier Exit (Short, 3 ATRs ) 52.58
Upper Bollinger Band 53.24
Lower Bollinger Band 44.33
Percent B (%b) 0.96
BandWidth 18.28
MACD Line 1.45
MACD Signal Line 0.94
MACD Histogram 0.5113
Fundamentals Value
Market Cap 2.81 Billion
Num Shares 53.2 Million
EPS -2.43
Price-to-Earnings (P/E) Ratio -21.76
Price-to-Sales 2.91
Price-to-Book 11.62
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 56.54
Resistance 3 (R3) 56.78 55.79 55.93
Resistance 2 (R2) 55.79 54.85 55.67 55.72
Resistance 1 (R1) 54.33 54.28 55.06 54.09 55.52
Pivot Point 53.34 53.34 53.71 53.22 53.34
Support 1 (S1) 51.88 52.41 52.61 51.65 50.22
Support 2 (S2) 50.89 51.83 50.78 50.02
Support 3 (S3) 49.44 50.89 49.81
Support 4 (S4) 49.20